Company: XAIR
Filing Date: 2025-06-20
Form Type: 10-K
Source: 0001641172-25-015750
Chunk: 2304

Company: Beyond Air, Inc.
Filing Date: 2025-06-20
Form: 10-K
Item: Item 9A
Chunk 2304
---
, 382,000, 12,750 and 12,750 shares of NeuroNos’
common stock, respectively, with an exercise price of $0.14 per share, which was based on a third party valuation on the date of grant. 25% of the options vested in March 2025, with 25% vesting each year over three years
commencing on December 31, 2025.

Outstanding
Equity Awards as of March 31, 2025

    Equity awards
  
    Name 
    Date of Grant 
    Number of securities underlying unexercised options (#) exercisable  
    Number of securities underlying unexercised options (#) unexercisable  
    Equity incentive plan awards: Number of securities underlying unexercised unearned options (#)  
    Option exercise price ($)  
    Option expiration date  
    Number of shares or units of stock that have not vested (#)  
    Market value of shares or units of stock that have not vested ($) (5) 
  
    Steven A. Lisi 
    08/31/2018 
     400,000(1) 
     -  
     -  
     0.54  
     08/13/2029  
     -  
     - 

    03/31/2019 
     250,000(2) 
     -  
     -  
     0.54  
     03/31/2029  
     -  
     - 

    03/11/2020 
     70,000(2) 
     -  
     -  
     0.54  
     03/11/2030  
     -  
     - 

    03/04/2021 
     200,000(2) 
     -  
     -  
     0.54  
     03/04/2031  
     -  
     19,075 

    03/03/2022 
     210,000(2) 
     70,000  
     -  
     0.54  
     03/03/2032  
     -  
     109,000 

    03/29